Geode Capital Management
NVIV

Geode Capital Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,677
Closed -$13.6K 4734
2023
Q4
$13.6K Hold
18,677
﹤0.01% 4563
2023
Q3
$22.2K Buy
18,677
+7,508
+67% +$8.93K ﹤0.01% 4606
2023
Q2
$15.2K Hold
11,169
﹤0.01% 4688
2023
Q1
$11.8K Hold
11,169
﹤0.01% 4759
2022
Q4
$26K Hold
11,169
﹤0.01% 4731
2022
Q3
$47K Buy
11,169
+123
+1% +$518 ﹤0.01% 4781
2022
Q2
$44K Sell
11,046
-265,067
-96% -$1.06M ﹤0.01% 4805
2022
Q1
$95K Hold
276,113
﹤0.01% 4680
2021
Q4
$126K Hold
276,113
﹤0.01% 4652
2021
Q3
$192K Hold
276,113
﹤0.01% 4467
2021
Q2
$205K Buy
276,113
+89,401
+48% +$66.4K ﹤0.01% 4337
2021
Q1
$185K Buy
186,712
+142,642
+324% +$141K ﹤0.01% 4137
2020
Q4
$35K Buy
+44,070
New +$35K ﹤0.01% 4215
2020
Q1
Sell
-10,036
Closed -$2K 4292
2019
Q4
$2K Hold
10,036
﹤0.01% 4207
2019
Q3
$5K Hold
10,036
﹤0.01% 4192
2019
Q2
$7K Hold
10,036
﹤0.01% 4198
2019
Q1
$15K Hold
10,036
﹤0.01% 4111
2018
Q4
$15K Hold
10,036
﹤0.01% 4116
2018
Q3
$20K Hold
10,036
﹤0.01% 4095
2018
Q2
$17K Sell
10,036
-163,806
-94% -$277K ﹤0.01% 4043
2018
Q1
$93K Hold
173,842
﹤0.01% 3861
2017
Q4
$133K Sell
173,842
-5,960
-3% -$4.56K ﹤0.01% 3762
2017
Q3
$265K Hold
179,802
﹤0.01% 3577
2017
Q2
$485K Sell
179,802
-56,276
-24% -$152K ﹤0.01% 3364
2017
Q1
$956K Buy
236,078
+7,488
+3% +$30.3K ﹤0.01% 3040
2016
Q4
$960K Buy
228,590
+10,738
+5% +$45.1K ﹤0.01% 3009
2016
Q3
$1.48M Buy
217,852
+16,298
+8% +$111K ﹤0.01% 2731
2016
Q2
$1.16M Buy
201,554
+1,931
+1% +$11.2K ﹤0.01% 2818
2016
Q1
$1.39K Buy
199,623
+32,976
+20% +$230 ﹤0.01% 2697
2015
Q4
$1.2M Buy
166,647
+658
+0.4% +$4.73K ﹤0.01% 2804
2015
Q3
$1.43M Buy
+165,989
New +$1.43M ﹤0.01% 2657